« Return To News

Austin Drug Developer Gets $1.7M NIH Grant

Lung Therapeutics, Inc., an Austin-based pharmaceutical startup, has $1.69 million more to pump in the development of a drug that could help people afflicted with pneumonia.

AUSTIN BUSINESS JOURNAL

READ FULL ARTICLE